FDA to fast-track nine experimental drugs under new Trump program

The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup